Day: January 11, 2021

SmartFinancial Sets Fourth Quarter Earnings Release and Conference Call Dates

KNOXVILLE, Tenn., Jan. 11, 2021 (GLOBE NEWSWIRE) — SmartFinancial, Inc. (“SmartFinancial”) (NASDAQ:SMBK) announces details for the release of its results for the Fourth Quarter of 2020.SmartFinancial plans to issue its earnings release for the fourth quarter of 2020 on Tuesday, January 19, 2021, and will host a conference call on Wednesday, January 20, at 10:00 a.m. ET. To access this interactive teleconference, dial (888) 317-6003 or (412) 317-6061 and enter the confirmation number, 0205038. A replay of the conference call will be available through January 20, 2022, by dialing (877) 344-7529 or (412) 317-0088 and entering the confirmation number, 10151327.Conference call materials (earnings release & conference call presentation) will be published on the company’s webpage located at http://www.smartfinancialinc.com/CorporateProfile...

Continue reading

American National Bankshares Inc. Announces Share Repurchase Authorization

DANVILLE, Va., Jan. 11, 2021 (GLOBE NEWSWIRE) — American National Bankshares Inc. (“American National”) (NASDAQ: AMNB), parent company of American National Bank and Trust Company, today announced that its Board of Directors has authorized the repurchase of up to 350,000 shares of American National’s outstanding common stock through December 31, 2021. Repurchases may be made through open market purchases or in privately negotiated transactions at prevailing market prices. The actual means and timing of any purchases, target number of shares and range of prices under the program will be determined by management in its discretion and will depend on a number of factors, including the market price of the shares, general market and economic conditions, share issuances under equity plans, and applicable legal requirements and other conditions.About...

Continue reading

Mesoblast Presents Heart Failure Phase 3 Trial Results at Investor Healthcare Conference

NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that its Chief Executive Officer, Dr Silviu Itescu, today presented additional data from the landmark DREAM-HF Phase 3 trial in patients with chronic heart failure. The presentation materials have been lodged with the ASX, and Mesoblast’s presentation at the H.C. Wainwright Virtual BioConnect 2021 Conference can be accessed at https://journey.ct.events/view/f353f7fd-772e-43aa-aab0-e959da38254d. An archived webcast of the conference presentation will be available for 90 days on the Company’s website at www.mesoblast.com.The randomized controlled Phase 3 trial compared clinical outcomes between rexlemestrocel-L and sham control in 537 treated patients with chronic...

Continue reading

Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics™), today announced that clinical data from its Phase 1 dose escalation study of MCLA-158 will be presented in a poster session at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium (ASCO GI) annual meeting being held virtually from January 15-17, 2021.“We are pleased that MCLA-158 treatment was well tolerated in patients and that we have reached the recommended phase 2 dose,” said Andrew Joe, MD, Chief Medical Officer of Merus. “The dose expansion phase is continuing with enrollment of patients with gastric and other non-CRC cancers.”E-Poster...

Continue reading

Lindsey Fudge Joins California Bank of Commerce as Senior Relationship Manager

SACRAMENTO, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) — California Bank of Commerce (CBC) is expanding its Sacramento team with the addition of Lindsey Fudge as a Senior Relationship Manager specializing in commercial real estate lending.“Lindsey’s deep knowledge of the market and creative problem-solving skills will be an asset to both our team and our clients,” said Scott Myers, Senior Executive Vice President and Chief Lending Officer of California Bank of Commerce.Fudge joins CBC from First Bank, where she most recently served as Senior Vice President of Commercial Real Estate. Prior to First Bank, Fudge held various roles at Wells Fargo including Relationship Manager for the Real Estate Group and she successfully completed Wells Fargo’s Credit Management Training Program. In 2016, Fudge was awarded the “40 Under 40” recognition...

Continue reading

INCB001158 Biliary Tract Cancer Data to be Presented at 2021 Virtual ASCO Gastrointestinal Cancers Symposium

SOUTH SAN FRANCISCO, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced that preliminary safety and efficacy data from a trial evaluating the arginase inhibitor INCB001158, which is being developed by Incyte Pharmaceuticals, will be presented in a virtual poster session at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Virtual Symposium taking place January 15-17, 2021.Presentation details:Date: Available starting on Friday, January 15 at 5:00 a.m. Pacific TimeTitle: A phase I/II study of safety and efficacy of the arginase inhibitor INCB001158 plus chemotherapy in patients with advanced...

Continue reading

General Finance Corporation Confirms Full Redemption of 8.125% Senior Notes Due 2021

PASADENA, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) — General Finance Corporation (NASDAQ:GFN), a leading specialty rental services company offering portable storage, modular space and liquid containment solutions (the “Company”), confirmed that on January 15, 2021 (as previously announced on December 16, 2020) it will complete the redemption of its remaining $11.6 million outstanding 8.125% Senior Notes due July 2021 (the “Notes”). The redemption price will be $25 per Note (equal to 100% of the Notes’ original principal amount), plus accrued and unpaid interest through, but excluding, the Redemption Date, January 15, 2021. It is expected that the last day of trading of the Notes will be January 14, 2021.As a result of the redemption of the Notes in their entirety, the Notes will be delisted from the NASDAQ Global Market Stock Exchange...

Continue reading

Acacia Communications Files Counterclaim Against Cisco

MAYNARD, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) — Acacia Communications, Inc. (Nasdaq: ACIA) (“Acacia” or “the Company”) today announced that it filed its answer and affirmative defenses in response to the complaint filed by Cisco Systems, Inc. (Nasdaq: CSCO) (“Cisco”) in the Delaware Court of Chancery and simultaneously filed a counterclaim against Cisco seeking a declaration that Acacia validly terminated the merger agreement with Cisco because the required Chinese regulatory approval was not obtained and the merger did not close before the agreed-upon termination date under the agreement. As previously announced, on January 8, 2021, Acacia delivered to Cisco a notice to terminate the merger agreement for the proposed acquisition of Acacia by Cisco. The transaction was conditioned on the satisfaction or mutual waiver of agreed-upon...

Continue reading

RADA Announces its Plans to Dual-List its Ordinary Shares on the Tel Aviv Stock Exchange

NETANYA, Israel, Jan. 11, 2021 (GLOBE NEWSWIRE) — RADA Electronic Industries Ltd. (NASDAQ: RADA) announced today that its Board of Directors has approved the submission of a listing application to have its ordinary shares dual-listed on the Tel Aviv Stock Exchange (“TASE”). Upon listing on the TASE the Company’s ordinary shares will continue to trade as usual on NASDAQ and the Company will continue to comply with the reporting and disclosure requirements of the U.S. Securities and Exchanges Commission applicable to foreign private issuers.Yossi Ben Shalom, Chairman of the Board of Directors of RADA, stated: “We look forward to our listing on the Tel Aviv Stock Exchange, which we believe will enable us to broaden our investor base and bring us an increased interest and investment from Israeli institutions. For Israeli...

Continue reading

W&T Offshore Provides Operational and Financial Update

HOUSTON, Jan. 11, 2021 (GLOBE NEWSWIRE) — W&T Offshore, Inc. (NYSE: WTI) (“W&T” or the “Company”) today provided an operational and financial update regarding several matters including the consolidation of its two Alabama natural gas treatment facilities, the awarding of two blocks from the November 2020 federal Gulf of Mexico (“GOM”) lease sale, the semi-annual redetermination of the borrowing base under its revolving credit facility, and new crude oil hedges added.Consolidation of Alabama Natural Gas Treatment FacilitiesW&T has substantially completed the consolidation of its two onshore natural gas treatment facilities that service the Mobile Bay area into the Onshore Treating Facility (“OTF”) which was acquired in 2019 from ExxonMobil. W&T is in the final stages of closing its Yellowhammer Plant and expects...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.